Stay updated on Pembrolizumab for Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded a recruitment status notice 'No longer looking for participants' and introduced new user guidance sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'), improving clarity and navigation for study records. Replaced the label 'Intervention / Treatment' with 'Intervention/Treatment' and updated revision information by removing 'Revision: v3.5.5' and adding 'Revision: v3.6.0'.SummaryDifference0.5%

- Check16 days agoChange DetectedThe page now displays Revision: v3.5.5, indicating an updated version of the record; the change appears to be administrative/version tracking rather than content changes to the clinical trial information.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a new site build/version. This represents an internal update rather than a change to the visible study content.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3, reflecting a minor site release rather than a change to the trial details.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check95 days agoChange DetectedThe page revision label was updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page.